Inovio Pharmaceuticals SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 6, 2026, 4:06 p.m. ETView on SEC.gov
Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
8-KAug. 12, 2026, 4:07 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
10-QAug. 12, 2026, 4 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 12, 2026, 12:02 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 7, 2026, 4:13 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 6, 2026, 10:31 a.m. ETView on SEC.gov
SCHEDULE 13GJuly 31, 2026, 10:20 a.m. ETView on SEC.gov
8-KJuly 31, 2026, 7:23 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Other events · Financial statements and exhibits
424B5July 30, 2026, 5:27 p.m. ETView on SEC.gov
8-KJuly 29, 2026, 4:03 p.m. ETView on SEC.gov
Results of operations and financial condition
424B5July 29, 2026, 4:01 p.m. ETView on SEC.gov